Relay Therapeutics Inc

NASDAQ:RLAY  
37.56
-2.43 (-6.08%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.16B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$12.5 Million
Adjusted EPS$0.05
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Relay Therapeutics, Inc. Stock, NASDAQ:RLAY

399 Binney Street, 2nd floor, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.370.8837
Number of Employees: 122

Description

Relay Therapeutics, Inc. is a clinical-stage precision medicines company. It focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.